318 related articles for article (PubMed ID: 15632000)
1. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye.
Pflugfelder SC; Farley W; Luo L; Chen LZ; de Paiva CS; Olmos LC; Li DQ; Fini ME
Am J Pathol; 2005 Jan; 166(1):61-71. PubMed ID: 15632000
[TBL] [Abstract][Full Text] [Related]
2. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline.
De Paiva CS; Corrales RM; Villarreal AL; Farley W; Li DQ; Stern ME; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2847-56. PubMed ID: 16799024
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
De Paiva CS; Corrales RM; Villarreal AL; Farley WJ; Li DQ; Stern ME; Pflugfelder SC
Exp Eye Res; 2006 Sep; 83(3):526-35. PubMed ID: 16643899
[TBL] [Abstract][Full Text] [Related]
4. Essential role for c-Jun N-terminal kinase 2 in corneal epithelial response to desiccating stress.
De Paiva CS; Pangelinan SB; Chang E; Yoon KC; Farley WJ; Li DQ; Pflugfelder SC
Arch Ophthalmol; 2009 Dec; 127(12):1625-31. PubMed ID: 20008718
[TBL] [Abstract][Full Text] [Related]
5. Low humidity environmental challenge causes barrier disruption and cornification of the mouse corneal epithelium via a c-jun N-terminal kinase 2 (JNK2) pathway.
Pelegrino FS; Pflugfelder SC; De Paiva CS
Exp Eye Res; 2012 Jan; 94(1):150-6. PubMed ID: 22166618
[TBL] [Abstract][Full Text] [Related]
6. EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease.
Huet E; Vallée B; Delbé J; Mourah S; Prulière-Escabasse V; Tremouilleres M; Kadomatsu K; Doan S; Baudouin C; Menashi S; Gabison EE
Am J Pathol; 2011 Sep; 179(3):1278-86. PubMed ID: 21777561
[TBL] [Abstract][Full Text] [Related]
7. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
8. 0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice.
Yang Y; Huang C; Lin X; Wu Y; Ouyang W; Tang L; Ye S; Wang Y; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3375-3384. PubMed ID: 30025085
[TBL] [Abstract][Full Text] [Related]
9. Dry eye symptoms are increased in mice deficient in phospholipid transfer protein (PLTP).
Setälä NL; Metso J; Jauhiainen M; Sajantila A; Holopainen JM
Am J Pathol; 2011 May; 178(5):2058-65. PubMed ID: 21514421
[TBL] [Abstract][Full Text] [Related]
10. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium.
Corrales RM; Stern ME; De Paiva CS; Welch J; Li DQ; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3293-302. PubMed ID: 16877394
[TBL] [Abstract][Full Text] [Related]
11. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome.
Chotikavanich S; de Paiva CS; Li de Q; Chen JJ; Bian F; Farley WJ; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3203-9. PubMed ID: 19255163
[TBL] [Abstract][Full Text] [Related]
12. Desiccating stress decreases apical corneal epithelial cell size--modulation by the metalloproteinase inhibitor doxycycline.
Beardsley RM; De Paiva CS; Power DF; Pflugfelder SC
Cornea; 2008 Sep; 27(8):935-40. PubMed ID: 18724157
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study.
Shoari A; Kanavi MR; Rasaee MJ
Exp Eye Res; 2021 Apr; 205():108523. PubMed ID: 33662353
[TBL] [Abstract][Full Text] [Related]
14. Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
Zhang X; Lin X; Liu Z; Wu Y; Yang Y; Ouyang W; Li W; Liu Z
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6056-6064. PubMed ID: 29204644
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
16. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis.
Chen W; Zhang X; Liu M; Zhang J; Ye Y; Lin Y; Luyckx J; Qu J
Exp Eye Res; 2009 Sep; 89(3):311-8. PubMed ID: 19345212
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
Seo MJ; Kim JM; Lee MJ; Sohn YS; Kang KK; Yoo M
Curr Eye Res; 2010 Feb; 35(2):165-75. PubMed ID: 20136427
[TBL] [Abstract][Full Text] [Related]
18. Diurnal variation of tight junction integrity associates inversely with matrix metalloproteinase expression in Xenopus laevis corneal epithelium: implications for circadian regulation of homeostatic surface cell desquamation.
Wiechmann AF; Ceresa BP; Howard EW
PLoS One; 2014; 9(11):e113810. PubMed ID: 25412440
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system.
Li J; Roubeix C; Wang Y; Shi S; Liu G; Baudouin C; Chen W
Mol Vis; 2012; 18():317-29. PubMed ID: 22355243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
